Neuromuscular Block in Laryngeal Mask Airway(LMA) Insertion

Seoul National University logo

Seoul National University

Status

Completed

Conditions

Breast Disease
General Anesthesia

Treatments

Drug: use of rocuronium when the LMA is inserted

Study type

Interventional

Funder types

Other

Identifiers

NCT01035021
LMA_M_relax

Details and patient eligibility

About

The aim of this study is to evaluate the success rate, insertion time and complication depending on the use of neuromuscular blocking agent when inserting the laryngeal mask airway (LMA).

Enrollment

160 patients

Sex

Female

Ages

18 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • 18-70 year
  • american society of anesthesiologist status 1-2
  • elective general anesthesia

Exclusion criteria

  • known or predicted difficult airway
  • recent sore throat
  • mouth opening less than 2.5 cm
  • at risk of aspiration

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

160 participants in 2 patient groups

group N
Active Comparator group
Description:
Anesthesia is induced with propofol and remifentanil and LMA is inserted by the standard technique according to eht manufacturer's instruction. Rocuronium is administered for the operation.
Treatment:
Drug: use of rocuronium when the LMA is inserted
group R
Active Comparator group
Description:
Anesthesia is induced with a propofol and remifentanil and rocuronium 0.06 mg/kg is injected. Insertion of LMA is performed by the standard technique according to the manufacturer's instruction.
Treatment:
Drug: use of rocuronium when the LMA is inserted

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems